Short antibiotic treatment courses or how short is short?

International Journal of Antimicrobial Agents

Volumn 30, Issue SUPPL. 1, 2007, Pages 76-79

  Rubinstein, Ethan ^a  

^a Section of Infectious Diseases   (Canada)

Author keywords

Abbreviated therapy; Antibiotics; Therapy duration

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CHLORAMPHENICOL; GLYCOPEPTIDE; IMIDAZOLE; MACROLIDE; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CATHETER INFECTION; ENTEROCOCCUS; EPIDEMIC MENINGITIS; HUMAN; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA CHOLERAESUIS; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SHORT COURSE THERAPY; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; TYPHOID FEVER; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY; HUMANS; TIME FACTORS;

EID: 34848869365     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.06.017     Document Type: Article

References (18)

1. Williams J.D., Brumfitt W., Leigh D., and Percival A. Eradication of bacteruria in pregnancy by a short course of chemotherapy. Lancet 1 (1965) 831
2. East Africa and British Research Councils. Controlled clinical trial of short-course (6 month) regimens of chemotherapy for the treatment of pulmonary tuberculosis. Lancet 1972; 1:1105-6.
3. Guillemot D., Carbon C., Balkau B., et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 279 (1998) 365-370
4. Tran T.H., Bethell D.B., Nguyen T.T., et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 20 (1995) 917-923
5. Vinh H., Wain J., Vo T.N., et al. Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob Agents Chemother 40 (1996) 958-961
6. Parry C.M., Ho V.A., Phuong le T., et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 51 (2007) 819-825
7. Nathan N., Borel T., Djibo A., et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet 366 (2005) 308-313
8. Briggs S., Ellis-Pegler R., Roberts S., Thomas M., and Woodhouse A. Short course intravenous benzylpenicillin treatment of adults with meningococcal disease. Intern Med J 34 (2004) 383-387
9. Ellis-Pegler R., Galler L., Roberts S., Thomas M., and Woodhouse A. Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults. Clin Infect Dis 37 (2003) 658-662
10. Eggimann P., and Pittet D. Infection control in the ICU. Chest 120 (2001) 2059-2093
11. Rosenthal V.D., Guzman S., and Orellano P.W. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 31 (2003) 291-295
12. Corona A., Wilson A.P., Grassi M., and Singer M. Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy. J Antimicrob Chemother 54 (2004) 809-817
13. Corona A., Wilson A.P., Grassi M., and Singer M. Short-course monotherapy strategy for treating bacteremia in the critically ill. Minerva Anestesiol 72 (2006) 841-857
14. Corona A., Bertolini G., Ricotta A.M., Wilson A.P., and Singer M. Variability of treatment duration for bacteraemia in the critically ill: a multinational survey. J Antimicrob Chemother 52 (2003) 849-852
15. Fagon J.Y., Chastre J., Hance A.J., et al. Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis 138 (1988) 110-116
16. Seidenfeld J.J., Pohl D.F., Bell R.C., Harris G.D., and Johanson Jr. W.G. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 134 (1986) 12-16
17. Chastre J., Wolff M., Fagon J.Y., et al., PneumA Trial Group. Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290 (2003) 2588-2598
18. el Moussaoui R., de Borgie C.A., van den Broek P., et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 332 (2006) 1355-1359